Xiaochen Hu
Impact in
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Inflammatory Biomarkers in Disease Prognosis
-
- Cancer-related molecular mechanisms research
Papers in
- Oncology 8
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Gustavo Bajotto (2 shared papers)Juichi Sato (4 shared papers)Yuzo Sato (3 shared papers)Yoshiharu Oshida (2 shared papers)Ming Xu (1 shared paper)Kah Keng Wong (1 shared paper)C Jin (1 shared paper)Takahiro Maeda (1 shared paper)
- Journals
- World Journal of Pediatrics (2 papers)Technology in Cancer Research & Treatment (1 paper)Diabetes Research and Clinical Practice (1 paper)Molecular Biology Reports (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Xiaochen Hu
26 papers receiving 523 citations
Peers
Comparison fields: 5 of 77
- Oncology 188
- Cancer Research 72
- Endocrinology, Diabetes and Metabolism 65
- Complementary and alternative medicine 30
- Pharmacology 31
Countries citing papers authored by Xiaochen Hu
This map shows the geographic impact of Xiaochen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Hu more than expected).
Fields of papers citing papers by Xiaochen Hu
This network shows the impact of papers produced by Xiaochen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Hu. The network helps show where Xiaochen Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochen Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 110 | |
| 2 | 2003 | 110 | |
| 3 | 2012 | 50 | |
| 4 | 2016 | 35 | |
| 5 | 2019 | 33 | |
| 6 | 2016 | 25 | |
| 7 | 2021 | 17 | |
| 8 | Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbine. | 2014 | 17 |
| 9 | 2011 | 16 | |
| 10 | 2020 | 16 | |
| 11 | 2014 | 16 | |
| 12 | 2021 | 15 | |
| 13 | 2020 | 13 | |
| 14 | 2021 | 12 | |
| 15 | 2016 | 11 | |
| 16 | 2021 | 11 | |
| 17 | 2010 | 10 | |
| 18 | 2010 | 8 | |
| 19 | 2018 | 7 | |
| 20 | Cell-free DNA in blood and urine as a diagnostic tool for bladder cancer: a meta-analysis. | 2018 | 6 |
About Xiaochen Hu
Xiaochen Hu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Pharmacology and Immunology, having authored 26 papers that have together received 553 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Traditional Chinese Medicine Analysis (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (188 citations), Cancer Research (72 citations), Endocrinology, Diabetes and Metabolism (65 citations), Complementary and alternative medicine (30 citations) and Pharmacology (31 citations). Xiaochen Hu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Gustavo Bajotto, Juichi Sato, Yuzo Sato, Yoshiharu Oshida, Ming Xu, Kah Keng Wong, C Jin, Takahiro Maeda, D Kufe and Audrey Bouillez. Their work appears in journals such as World Journal of Pediatrics, Technology in Cancer Research & Treatment, Diabetes Research and Clinical Practice, Molecular Biology Reports and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.